It’s not just the “innovative” and “exotic” creations of a deregulated Wall Street that harm the public. Big Pharma is just as guilty of creating monsters.
Opponents of a national health care system for all U.S. citizens argue that such a system would cripple the privatized system’s ability to “innovate,” thus stifling the creation of new drugs.
But Stephanie Saul’s article, “Experts Conclude Pfizer Manipulated Studies,” in today’s New York Times shows that innovation at Pfizer sometimes has less to do with research than finding innovative ways to sell drugs – like, for example innovatively fudging the research so it looks like the epilepsy medicine Neurontin can treat conditions like bipolar disorder and migraine headaches, even when it can’t.
